JP2025500942A5 - - Google Patents

Info

Publication number
JP2025500942A5
JP2025500942A5 JP2024537006A JP2024537006A JP2025500942A5 JP 2025500942 A5 JP2025500942 A5 JP 2025500942A5 JP 2024537006 A JP2024537006 A JP 2024537006A JP 2024537006 A JP2024537006 A JP 2024537006A JP 2025500942 A5 JP2025500942 A5 JP 2025500942A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
independently
hydrogen
alkanediyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537006A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500942A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/082020 external-priority patent/WO2023122587A2/en
Publication of JP2025500942A publication Critical patent/JP2025500942A/ja
Publication of JP2025500942A5 publication Critical patent/JP2025500942A5/ja
Pending legal-status Critical Current

Links

JP2024537006A 2021-12-20 2022-12-20 トリペプチドリンカーおよびその使用方法 Pending JP2025500942A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163291918P 2021-12-20 2021-12-20
US63/291,918 2021-12-20
PCT/US2022/082020 WO2023122587A2 (en) 2021-12-20 2022-12-20 Tripeptide linkers and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025500942A JP2025500942A (ja) 2025-01-15
JP2025500942A5 true JP2025500942A5 (https=) 2025-12-26

Family

ID=86903742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537006A Pending JP2025500942A (ja) 2021-12-20 2022-12-20 トリペプチドリンカーおよびその使用方法

Country Status (7)

Country Link
US (1) US20250262315A1 (https=)
EP (1) EP4452292A2 (https=)
JP (1) JP2025500942A (https=)
CN (1) CN118632857A (https=)
AU (1) AU2022420583A1 (https=)
CA (1) CA3240164A1 (https=)
WO (1) WO2023122587A2 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1826199A1 (en) * 2006-02-27 2007-08-29 Technische Universität Wien Modified amino acids
AR060385A1 (es) * 2006-04-11 2008-06-11 Novartis Ag Compuestos organicos y sus usos

Similar Documents

Publication Publication Date Title
US11510959B2 (en) Hydrophilic antibody-drug conjugates
CA2088367C (en) Tri- and tetra-valent monospecific antigen-binding proteins
US6511663B1 (en) Tri- and tetra-valent monospecific antigen-binding proteins
TWI852735B (zh) 四級胺化妥布賴森(tubulysin)化合物之結合物
AU2022219525B2 (en) Bivalent fibroblast activation protein ligands for targeted delivery applications
CN114929284A (zh) 喜树碱肽缀合物
BR112020020466A2 (pt) Conjugados de peptídeo de camptotecina
EP4313157A1 (en) Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties
WO2020035027A1 (zh) 连接子、含连接子的抗体偶联药物及连接子的用途
CN102724967A (zh) 包括可释放的脲连接体的含芳香胺化合物的聚合缀合物
JP2002543111A (ja) ポリマーを使用する葉酸で仲介された腫瘍細胞へのターゲッティングの増幅
JP2022547434A (ja) 標的化デンドリマー複合体
JPS63503144A (ja) 葉酸類縁体のアミン誘導体
EP4565277A1 (en) Conjugates of psma-binding moieties with cytotoxic agents
EP4043452A1 (en) Bivalent fibroblast activation protein ligands for targeted delivery applications
CN116917278A (zh) 用于靶向递送应用的二价成纤维细胞活化蛋白配体
JP2025500942A5 (https=)
JP2022514348A (ja) チオール多重リンカーを有するadc
CN114409562B (zh) 一种ca4衍生物及其配体-药物偶联物
TWI903241B (zh) 一種帶有高穩定性親水連接單元的奧瑞他汀類藥物及其偶聯物
JP2022532801A5 (https=)
WO2026074296A1 (en) Linkers and protein and peptide conjugates incorporating the same
CN121079107A (zh) 一种连接子、抗体药物偶联物及其制备方法
HK40111230A (zh) 用於靶向细胞表面受体的可裂解放射性配体及其用途
TW202546005A (zh) 抗體-奧瑞他汀藥物偶聯物以及其製造及使用方法